SAMANTHA COLLINS: Open Payments
NPI 1740745876 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 30 payments from 7 companies in 2025. Trend: 2023 $98 · 2024 $175 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $196 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Calliditas Therapeutics US Inc. | 2 | $64 |
| Lilly USA, LLC | 2 | $35 |
| Novo Nordisk Inc | 1 | $21 |
| Ardelyx, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
Products named: Fabhalta, JYNARQUE, TARPEYO, JARDIANCE, Ozempic, IBSRELA, ONPATTRO, Vanrafia.
Industry payments across NC — which companies pay providers there.
